###begin article-title 0
###xml 116 120 <span type="species:ncbi:10090">Mice</span>
PERK Regulates the Proliferation and Development of Insulin-Secreting Beta-Cell Tumors in the Endocrine Pancreas of Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: SG BM DRC. Performed the experiments: SG DRC. Analyzed the data: SG BM DRC. Contributed reagents/materials/analysis tools: DRC. Wrote the paper: SG BM DRC.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
PERK eIF2alpha kinase is required for the proliferation of the insulin-secreting beta- cells as well as insulin synthesis and secretion. In addition, PERK signaling has been found to be an important factor in determining growth and angiogenesis of specific types of tumors, and was attributed to PERK-dependent regulation of the hypoxic stress response. In this report we examine the role of PERK in regulating proliferation and angiogenesis of transformed beta-cells in the development of insulinomas.
###end p 3
###begin title 4
Methodology
###end title 4
###begin p 5
###xml 99 106 99 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk KO</italic>
###xml 4 8 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
The SV40 Large T-antigen (Tag) was genetically introduced into the insulin secreting beta-cells of Perk KO mice under the control of an inducible promoter. Tumor growth and the related parameters of cell proliferation were measured. In late stage insulinomas the degree of vascularity was determined.
###end p 5
###begin title 6
Principal Findings
###end title 6
###begin p 7
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 219 223 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 349 353 349 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 508 512 508 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
###xml 523 527 <span type="species:ncbi:10090">mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
The formation and growth of insulinomas in Perk-deficient mice was dramatically ablated with much fewer tumors, which averaged 38-fold smaller than seen in wild-type control mice. Beta-cell proliferation was ablated in Perk-deficient mice associated with reduced tumor growth. In the small number of large encapsulated insulinomas that developed in Perk-deficient mice, we found a dramatic reduction in tumor vascularity compared to similar sized insulinomas in wild-type mice. Although insulinoma growth in Perk-deficient mice was largely impaired, beta-cell mass was increased sufficiently by T-antigen induction to rescue the hypoinsulinemia and diabetes in these mice.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
We conclude that PERK has two roles in the development of beta-cell insulinomas, first to support rapid cell proliferation during the initial transition to islet hyperplasia and later to promote angiogenesis during the progression to late-stage encapsulated tumors.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 239 242 235 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Rosenwald1">[1]</xref>
###xml 244 247 240 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Meurs1">[2]</xref>
###xml 249 252 245 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Raught1">[3]</xref>
###xml 254 257 250 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Clemens1">[4]</xref>
###xml 515 518 507 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Fels1">[5]</xref>
###xml 520 523 512 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Bi1">[6]</xref>
###xml 525 528 517 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Blais1">[7]</xref>
###xml 560 564 552 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 690 694 682 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 702 705 694 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Harding1">[8]</xref>
###xml 739 742 731 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Bi1">[6]</xref>
###xml 744 747 736 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Blais1">[7]</xref>
###xml 866 870 858 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 870 873 862 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Bi1">[6]</xref>
###xml 875 878 867 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Blais1">[7]</xref>
###xml 947 951 939 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 1121 1124 1113 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Bi1">[6]</xref>
###xml 1126 1129 1118 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Blais1">[7]</xref>
###xml 259 265 <span type="species:ncbi:9606">Humans</span>
###xml 729 738 <span type="species:ncbi:10090">nude mice</span>
Tumor growth is dependent upon high rates of protein synthesis, and previous studies had shown that control of protein synthesis mediated by phosphorylation of the translation initiation factor eIF2alpha is important for tumor progression [1], [2], [3], [4]. Humans and other mammals have four eIF2alpha kinases including GCN2, HRI, PKR and PERK. Previous studies have shown that tumors that lack PERK-mediated signaling tend to be smaller and this was found to be correlated with smaller hypoxic microenvironments [5], [6], [7]. In these studies immortalized Perk-deficient MEFs transformed with oncogenic Ki-RasV12 or HT29 colorectal carcinoma cells stably expressing a dominant negative Perk allele [8] were transplanted into nude mice [6], [7]. The resultant tumors were found to be smaller and less vascular compared to control implants that were wild type for Perk[6], [7]. However, in these studies, the dramatic reduction in growth of the Perk-deficient tumors was attributed to increased rates of apoptotic cell death and impaired angiogenesis but, inexplicably, tumor cell proliferation rates were not examined [6], [7].
###end p 11
###begin p 12
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 183 186 183 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Delepine1">[9]</xref>
###xml 226 230 226 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Harding2">[10]</xref>
###xml 245 249 245 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Iida1">[11]</xref>
###xml 251 255 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Zhang1">[12]</xref>
###xml 292 299 292 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk KO</italic>
###xml 461 465 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Zhang2">[13]</xref>
###xml 571 575 571 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Zhang2">[13]</xref>
###xml 587 591 587 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 661 665 661 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Wei1">[14]</xref>
###xml 19 25 <span type="species:ncbi:9606">humans</span>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
Perk deficiency in humans is the cause of the Wolcott-Rallison Syndrome characterized by permanent neonatal diabetes, exocrine pancreas deficiency, osteopenia, and growth retardation [9] and these defects are recapitulated in Perk KO mice [10], [11], [12]. We discovered that the diabetes in Perk KO mice was due to hypoinsulinemia associated with low insulin-secreting beta-cell mass caused by diminished beta-cell proliferation and impaired insulin secretion [13]. Gene expression analyses revealed reduced expression of factors vital to the G2-M cell cycle transition [13]. Moreover, Perk-deficient osteoblasts exhibited reduced levels of cell proliferation [14]. Having established the importance of PERK in beta-cell proliferation we decided to investigate whether PERK played an important role in the progression of insulinomas, a pancreatic beta-cell cancer.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 37 41 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 96 100 <span type="species:ncbi:10090">Mice</span>
Growth of Insulinomas Induced by the SV40 Large T-Antigen Is Severely Blunted in PERK-Deficient Mice
###end title 14
###begin p 15
###xml 123 130 123 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet-Tag</italic>
###xml 149 158 149 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP7-rtTA</italic>
###xml 205 212 205 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;Tag</italic>
###xml 307 311 304 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Berkovich1">[15]</xref>
###xml 353 360 350 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk KO</italic>
###xml 362 365 359 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO</italic>
###xml 395 399 392 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 494 501 488 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;Tag</italic>
###xml 516 526 507 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 585 596 573 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008008-g001">Figure 1A&#8211;B</xref>
###xml 730 739 718 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008008-g001">Figure 1C</xref>
###xml 741 745 729 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Berkovich1">[15]</xref>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 37 41 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 528 532 <span type="species:ncbi:10090">mice</span>
To generate insulinomas in mice, the SV40 Large T-Antigen was introduced using a bipartite genetic system comprised of the tet-Tag transgene and the RIP7-rtTA transgene. Together these transgenes (denoted betaTag) provide beta-cell specific, doxycycline-inducible control of the expression of the T-antigen [15]. These strains were further crossed into Perk KO (PKO) mice to study the effect of Perk on postnatal beta-cell proliferation. As reported previously, we found that the expression of betaTag in wild-type (WT-betaTag) mice caused islet hyperplasia by postnatal day 40 (p40) (Figure 1A-B), and these hyperplastic islets progressed to highly vascular insulinomas associated with hyperinsulinemia and hypoglycemia (arrows, Figure 1C) [15]. Serum insulin increased by >40-fold compared to normal in some animals (not shown).
###end p 15
###begin title 16
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
The growth of beta-cell insulinomas is ablated in Perk-deficient mice.
###end title 16
###begin p 17
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 3 4 3 4 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 19 27 19 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wildtype</italic>
###xml 29 31 29 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</italic>
###xml 44 45 44 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 59 60 59 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 97 104 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;Tag</italic>
###xml 240 241 237 238 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 306 316 303 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 397 398 391 392 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 400 407 394 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk KO</italic>
###xml 409 412 403 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO</italic>
###xml 462 463 456 457 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 465 476 459 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 81 85 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 317 322 <span type="species:ncbi:10090">mouse</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 477 481 <span type="species:ncbi:10090">mice</span>
(A-B) Pancreata of wildtype (WT) mice with (A) or without (B) beta-cell specific SV40 T-antigen (betaTag) were examined histologically after hematoxlin and eosin staining to assess relative beta-cell hyperplasia at postnatal day 40 (p40). (C) Representative necropsy image of the whole pancreata of a p120 WT-betaTag mouse showing multiple insulinomas dispersed throughout the pancreas (arrows). (D) Perk KO (PKO) mice displayed relatively small islets at p14. (E) PKO-betaTag mice exhibited increased beta cell mass.
###end p 17
###begin p 18
###xml 18 25 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;Tag</italic>
###xml 27 31 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 95 104 92 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008008-g001">Figure 1D</xref>
###xml 144 148 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Zhang2">[13]</xref>
###xml 155 162 152 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk KO</italic>
###xml 226 230 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Zhang1">[12]</xref>
###xml 248 255 245 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;Tag</italic>
###xml 261 268 255 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk KO</italic>
###xml 275 286 269 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 359 368 350 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008008-g001">Figure 1E</xref>
###xml 548 556 539 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008008-g002">Figure 2</xref>
###xml 583 594 574 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 682 690 670 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008008-g002">Figure 2</xref>
###xml 794 801 782 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk KO</italic>
###xml 907 915 895 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008008-g003">Figure 3</xref>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
###xml 353 357 <span type="species:ncbi:10090">mice</span>
###xml 595 599 <span type="species:ncbi:10090">mice</span>
###xml 802 807 <span type="species:ncbi:10090">mouse</span>
In the absence of betaTag, Perk-deficient mice have a low beta-cell mass at postnatal day p14 (Figure 1D) and progress to overt diabetes by p21 [13]. Most Perk KO mice die due to numerous complications by 5 to 6 weeks of life [12]. Introduction of betaTag into Perk KO mice (PKO-betaTag) resulted in partial rescue of the beta-cell mass in p40 juvenile mice (Figure 1E) and delayed the onset of overt diabetes by one week. Remarkably, continued islet growth and increased beta-cell mass resulted in complete reversal of the diabetes by 7-10 weeks (Figure 2). Blood glucose levels in PKO-betaTag mice were found to peak by p35-p40, followed by a gradual progression to hypoglycemia (Figure 2). Although T-antigen expression was able to induce beta-cell proliferation and reverse diabetes in the Perk KO mouse, the size of their insulinomas were on average 38-fold smaller than seen in wild-type littermates (Figure 3).
###end p 18
###begin title 19
###xml 78 85 78 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk KO</italic>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Beta-cell hyperplasia caused by T-antigen transformation reverses diabetes in Perk KO mice.
###end title 19
###begin p 20
###xml 42 44 42 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</italic>
###xml 78 94 78 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wildtype-&#946;Tag</italic>
###xml 96 106 93 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 139 146 133 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk KO</italic>
###xml 148 151 142 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO</italic>
###xml 190 205 184 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk KO-&#946;Tag</italic>
###xml 207 218 198 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 382 385 370 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO</italic>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 386 390 <span type="species:ncbi:10090">mice</span>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
Serum glucose levels (mg/dl) in wildtype (WT, closed squares and solid line), wildtype-betaTag (WT-betaTag, open squares and dashed line), Perk KO (PKO, closed triangles and solid line) and Perk KO-betaTag (PKO-betaTag, open triangles and dashed line) littermates during postnatal progression of insulinoma development. Each data point is the mean of 4 to 13 mice. Serum glucose in PKO mice often exceeded the detection capability of the blood glucose monitor (600 mg/dl) and these mice didn't survive beyond p45. In this figure and all others, error bars = SEM.
###end p 20
###begin title 21
###xml 26 33 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;Tag</italic>
###xml 71 78 68 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk KO</italic>
Relative tumor volumes in betaTag induced insulinomas in wild type and Perk KO littermates.
###end title 21
###begin p 22
###xml 183 194 183 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 215 225 212 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 322 323 316 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
The insulinomas exhibited a nearly spherical shape and therefore tumor volumes were estimated as a function of their diameter. The tumor volumes of the largest insulinomas from three PKO-betaTag mice (n = 23) and 6 WT-betaTag mice (n = 19) at age p120 are plotted on a logarithmic scale showing a 38-fold difference. *****P<0.000005.
###end p 22
###begin title 23
###xml 63 74 63 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 75 79 <span type="species:ncbi:10090">Mice</span>
Beta-Cell Death Does Not Explain the Reduced Beta-Cell Mass in PKO-betaTag Mice
###end title 23
###begin p 24
###xml 108 119 108 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 203 214 200 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 219 229 213 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 450 460 441 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 478 489 466 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 524 535 509 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008008-g004">Figure 4A&#8211;C</xref>
###xml 588 598 573 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 703 712 685 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008008-g004">Figure 4D</xref>
###xml 903 913 885 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 978 987 957 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008008-g004">Figure 4C</xref>
###xml 1066 1076 1045 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 1086 1097 1062 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 461 465 <span type="species:ncbi:10090">mice</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
###xml 599 604 <span type="species:ncbi:10090">mouse</span>
###xml 914 918 <span type="species:ncbi:10090">mice</span>
###xml 1077 1081 <span type="species:ncbi:10090">mice</span>
###xml 1098 1102 <span type="species:ncbi:10090">mice</span>
To determine if differential cell death may be the cause for the relatively small size of the insulinoma in PKO-betaTag mice, we measured the percentage of beta-cells exhibiting TUNEL positive nuclei in PKO-betaTag and WT-betaTag mice during the exponential growth phase of the developing beta-cell tumors. Examination of islets smaller or larger than 1,000 beta-cells revealed that the percentage of TUNEL positive beta-cells was modestly higher in WT-betaTag mice compared to PKO-betaTag mice for both islet size classes (Figure 4A-C) but did not reach statistical significance. In one WT-betaTag mouse we examined an extraordinarily large tumor and found dense clusters of TUNEL positive beta-cells (Figure 4D). Within the local region of these clusters >10% of the beta-cells were TUNEL positive whereas the majority of the tumor exhibited a frequency of less than 1% similar to the other tumors in WT-betaTag mice. The data from this exceptional tumor were not included in Figure 4C. Although beta-cell death may contribute to the tumor size difference between WT-betaTag mice and PKO-betaTag mice these data suggest that cell death differences would tend to lessen the difference between these genotypes.
###end p 24
###begin title 25
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
Beta-cell death does not significantly contribute to tumor size differences between Perk genotypes.
###end title 25
###begin p 26
###xml 98 99 98 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 101 111 101 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 130 131 127 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 133 144 130 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 163 164 157 158 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 707 717 701 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 762 773 753 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 846 856 834 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 907 918 892 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 961 962 943 944 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1029 1039 1011 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 857 861 <span type="species:ncbi:10090">mice</span>
###xml 1040 1045 <span type="species:ncbi:10090">mouse</span>
TUNEL positive beta-cells were detected by immunohistochemistry. (TUNEL = red, insulin = green). (A) WT-betaTag islet p120, 40X, (B) PKO-betaTag islet p120, 40X, (C) Beta-cell death was estimated as the percentage of beta-cells (insulin positive) that exhibited a high level of DNA fragmentation as detected by TUNEL antibody in the nucleus. Islets were categorized into two groups: smaller than 1,000 beta-cells and larger than 1,000 beta-cells counted on a single cross-sectional area of each islet. The mean and standard error are shown for TUNEL positive beta-cells for each islet size class. No significant differences were seen between genotypes for either size class. For the small islet size class, WT-betaTag n = 27 islets (12,946 total beta-cells) and PKO-betaTag n = 20 islets (4,749 total beta-cells). For the large islet size class, WT-betaTag mice n = 20 islets (138,858 total beta-cells) and PKO-betaTag n = 12 islets (59,109 total beta-cells). (D) A small section of a very large beta-cell insulinoma from a p120 WT-betaTag mouse showing a high density of TUNEL positive beta-cells (40X). Four other distinct clusters of beta-cells also showed very high percentage of beta-cells that were TUNEL positive in this cross section of the tumor (not shown), whereas the majority of tumor exhibited a frequency of less than 1% TUNEL positive beta-cells. The TUNEL positive beta-cell clusters tend to be centrally located in the tumor.
###end p 26
###begin title 27
###xml 27 38 27 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 67 77 64 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 39 43 <span type="species:ncbi:10090">Mice</span>
###xml 78 82 <span type="species:ncbi:10090">Mice</span>
Beta-Cell Proliferation in PKO-betaTag Mice Is Reduced Compared to WT-betaTag Mice
###end title 27
###begin p 28
###xml 40 51 40 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 81 91 78 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 293 304 287 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 315 325 306 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 392 403 380 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 493 500 478 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008008-t001">Table 1</xref>
###xml 590 601 575 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 635 642 617 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;Tag</italic>
###xml 794 801 773 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008008-t001">Table 1</xref>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 602 606 <span type="species:ncbi:10090">mice</span>
The rates of beta-cell proliferation in PKO-betaTag mice and age and sex matched WT-betaTag littermates were estimated by BrdU incorporation. As larger neoplastic islets have higher rates of proliferation, beta-cell proliferation rates were assessed in uniform islets of less than 50 cells in PKO-betaTag and their WT-betaTag littermates at the following postnatal ages: p50, p100, and p120. PKO-betaTag islets showed a statistically significant 2.2 fold reduction in beta-cell proliferation (Table 1). Furthermore, rates of beta-cell proliferation were found to be consistently reduced in PKO-betaTag mice both in the early phases of betaTag induced islet hyperplasia at p50 (3.1 fold difference) as well as in the later stages of the progression to insulinomas at p120 (1.6 fold difference) (Table 1).
###end p 28
###begin title 29
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
Beta-cell proliferation is impaired in Perk-deficient, T-antigen transformed islets.
###end title 29
###begin p 30
###xml 89 100 89 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 110 120 107 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
Beta-cell proliferation rates were assessed by BrdU incorporation in age and sex matched PKO-betaTag mice and WT-betaTag littermates at postnatal ages p50, p100 and p120. Cells = insulin-positive beta-cells.
###end p 30
###begin p 31
###xml 258 265 258 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;Tag</italic>
###xml 294 305 291 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 349 356 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;Tag</italic>
###xml 429 433 420 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 532 539 523 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;Tag</italic>
###xml 610 614 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Berkovich1">[15]</xref>
###xml 808 812 796 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Berkovich1">[15]</xref>
###xml 975 979 963 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Martin1">[16]</xref>
###xml 1027 1031 1015 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 1189 1193 1177 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Zhang2">[13]</xref>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
###xml 462 466 <span type="species:ncbi:10090">mice</span>
###xml 1042 1046 <span type="species:ncbi:10090">mice</span>
Although the expression of the T-antigen in beta-cells leads to a dramatic increase in beta-cell proliferation in adult mice, we found that beta-cell masses at embryonic day 16.5 were not significantly different either between wild-type mice with or without betaTag expression as well as their PKO-betaTag littermates (not shown). Our findings that betaTag expression did not significantly affect beta-cell mass in wild-type and Perk-deficient mice in embryonic mice (e16.5) is consistent with previous reports that have shown that betaTag promotes postnatal beta-cell proliferation beginning at about 3 weeks [15]. Furthermore, Tag is an oncogene that functions primarily by inactivating the retinoblastoma protein (the main gate-keeper for the G1-S cell cycle checkpoint) and p53 (an inducer of apoptosis) [15], and previous studies have shown that the negative regulation of the G1-S cell cycle checkpoint does not significantly affect late-embryonic beta-cell neogenesis [16]. Our lab has also shown that beta-cell mass in Perk-deficient mice is comparable to their wild-type littermates in the early embryonic stages following neogenesis of beta-cells from endocrine progenitor cells [13].
###end p 31
###begin title 32
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 81 85 <span type="species:ncbi:10090">Mice</span>
T-Antigen Induced Insulinoma Vascularity Is Greatly Diminished in Perk-Deficient Mice
###end title 32
###begin p 33
###xml 91 95 91 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Berkovich1">[15]</xref>
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Mancuso1">[17]</xref>
###xml 180 189 180 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008008-g001">Figure 1E</xref>
###xml 284 294 284 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 352 365 349 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008008-g005">Fig. 5A, C, E</xref>
###xml 398 409 395 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 480 489 474 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008008-g005">Figure 5B</xref>
###xml 500 511 494 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 709 716 700 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk KO</italic>
###xml 815 826 806 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 840 849 828 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008008-g005">Figure 5G</xref>
###xml 924 935 912 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 994 1003 979 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008008-g005">Figure 5D</xref>
###xml 1040 1050 1025 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 1057 1066 1039 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008008-g005">Figure 5C</xref>
###xml 731 735 <span type="species:ncbi:10090">mice</span>
###xml 936 940 <span type="species:ncbi:10090">mice</span>
###xml 1051 1055 <span type="species:ncbi:10090">mice</span>
T-antigen induced beta-cell proliferation eventually leads to the formation of insulinomas [15], [17]. These insulinomas exhibited a marked increase in vascularity by 11-14 weeks (Figure 1E) compared to the initial stages of islet hyperplasia (4-6 weeks). Histological examination of WT-betaTag insulinomas at p120 revealed highly vascularized tumors (Fig. 5A, C, E). In contrast, insulinomas from PKO-betaTag littermates appeared to have significantly reduced tumor vascularity (Figure 5B). Because PKO-betaTag tumors are generally much smaller, their lack of vascularity could be simply due to a failure to progress to late stage insulinoma. To address this issue, we compared size-matched insulinomas from Perk KO and wild-type mice, and found a statistically significant 3-fold decrease in tumor vascularity in PKO-betaTag insulinomas (Figure 5G). Moreover, in the small number of very large encapsulated insulinomas in PKO-betaTag mice, we found a dramatic reduction in tumor vascularity (Figure 5D) compared to size-matched tumors in WT-betaTag mice (Figure 5C).
###end p 33
###begin title 34
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
Perk-deficient insulinomas exhibit dramatically reduced vascularity.
###end title 34
###begin p 35
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 3 4 3 4 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 5 6 5 6 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">:</bold>
###xml 29 39 29 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 41 45 38 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A, C</bold>
###xml 51 62 48 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 64 68 58 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B, D</bold>
###xml 133 143 127 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 145 146 136 137 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 152 163 143 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 165 166 153 154 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 243 244 231 232 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 334 344 322 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 359 360 344 345 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 486 497 471 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 507 517 489 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 674 685 653 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag:</italic>
###xml 841 852 817 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 1081 1092 1054 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 1097 1107 1067 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 1132 1136 1099 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">***P</italic>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
###xml 860 864 <span type="species:ncbi:10090">mice</span>
(A-D): Insulinomas from p120 WT-betaTag (A, C) and PKO-betaTag (B, D) mice stained with hematoxylin and eosin. Insulinomas from p120 WT-betaTag (E) and PKO-betaTag (F) littermates were stained for insulin (green), BrdU (red) and DAPI (blue). (E) Note the red autofluorescent signal from red blood cells within the highly vascularized WT-betaTag insulinomas. (G) The vascularized area in the cross sectional images of the islets were expressed as a percentage of the total islet area in PKO-betaTag mice and WT-betaTag littermates at p120. For each islet, the percentage vascularized area was plotted on the y-axis and the corresponding islet size was plotted on the x-axis. WT-betaTag: n = 2 mice, number of islets analyzed = 37, solid line represents the linear trend, average islet size = 1367.2, and the percent vascularized area = 8.9%. PKO-betaTag: n = 2 mice, number of islets analyzed = 30, dashed line represents the linear trend, average islet size = 898.3, and the percentage vascularized area = 2.9%. The difference in the average value of the vascularized area between PKO-betaTag and WT-betaTag was highly significant, ***P-value<0.0005.
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Naik1">[18]</xref>
###xml 209 213 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Pelengaris1">[19]</xref>
###xml 460 464 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Naik1">[18]</xref>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Pelengaris1">[19]</xref>
###xml 582 598 582 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wildtype-&#946;Tag</italic>
###xml 667 672 664 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk-</italic>
###xml 682 689 679 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;Tag</italic>
###xml 793 808 787 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk KO-&#946;Tag</italic>
###xml 948 964 939 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wildtype-&#946;Tag</italic>
###xml 1047 1062 1035 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk KO-&#946;Tag</italic>
###xml 1094 1109 1079 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk KO-&#946;Tag</italic>
###xml 1219 1223 1201 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 1340 1356 1322 1335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wildtype-&#946;Tag</italic>
###xml 1426 1433 1405 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk KO</italic>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
###xml 690 694 <span type="species:ncbi:10090">mice</span>
###xml 809 813 <span type="species:ncbi:10090">mice</span>
###xml 965 969 <span type="species:ncbi:10090">mice</span>
###xml 1063 1067 <span type="species:ncbi:10090">mice</span>
###xml 1286 1290 <span type="species:ncbi:10090">mice</span>
###xml 1357 1361 <span type="species:ncbi:10090">mice</span>
###xml 1472 1476 <span type="species:ncbi:10090">mice</span>
###xml 1580 1584 <span type="species:ncbi:10090">mice</span>
Previous studies have identified three distinct stages of T-antigen-induced beta-cell tumor progression including islet hyperplasia, islet-angiogenesis and finally formation of solid encapsulated tumors [18], [19]. The predominant determinant in the progression of normal islets to a stage of hyperplasia and angiogenesis was found to be the rate of beta-cell proliferation, while reduced apoptosis was critical in the progression to solid encapsulated tumors [18], [19]. As expected, we observed a similar progression to insulinomas and associated hyperinsulinemia-hypoglycemia in wildtype-betaTag mice. However, beta-cell proliferation was significantly reduced in Perk-deficient betaTag mice and this defect was most prominent in the initial transition to islet hyperplasia. Insulinomas in Perk KO-betaTag mice were fewer, the average size was 38-fold smaller, and they rarely develop into encapsulated tumors. Cell death was slightly higher in wildtype-betaTag mice and therefore does not appear to contribute to the smaller size of tumors in Perk KO-betaTag mice. Beta-cells isolated from Perk KO-betaTag insulinomas also showed poor growth characteristics in culture, and we were unable to establish a T-antigen, Perk-deficient beta-cell line from isolated insulinomas from these mice whereas we could readily establish them from the wildtype-betaTag mice. Although the T-antigen induction of beta-cell proliferation in Perk KO was blunted compared to the wild-type mice, the increase in beta-cell mass was nonetheless sufficient to eventually reverse the diabetes of these mice.
###end p 37
###begin p 38
###xml 134 137 134 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Fels1">[5]</xref>
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Brown1">[20]</xref>
###xml 272 276 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Folkman1">[21]</xref>
###xml 386 389 386 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Bi1">[6]</xref>
###xml 391 394 391 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Blais1">[7]</xref>
###xml 441 445 441 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 566 570 566 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 810 825 810 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk KO-&#946;Tag</italic>
###xml 861 877 858 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wildtype-&#946;Tag</italic>
###xml 1055 1063 1049 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-&#946;Tag</italic>
###xml 1175 1190 1166 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk KO-&#946;Tag</italic>
###xml 1526 1542 1514 1527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wildtype-&#946;Tag</italic>
###xml 1606 1621 1591 1603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk KO-&#946;Tag</italic>
###xml 1064 1068 <span type="species:ncbi:10090">mice</span>
###xml 1622 1626 <span type="species:ncbi:10090">mice</span>
During the later stages of tumor development hypoxia becomes more prevalent as cell growth outstrips the pre-existing vascular system [5], [20]. To provide increased circulation within the tumor microenvironment, angiogenesis is induced in part by the response to hypoxia [21]. PERK has been shown to be important for regulating the hypoxic stress response in fibroblast-derived tumors [6], [7] and it was speculated that the slow growth of Perk-deficient tumors was caused by a defect in the hypoxia-stress response resulting in increased cell death. We found that Perk-deficient insulinomas failed to develop extensive vasculature, consistent with the hypothesis that PERK plays a critical role in regulating the response to hypoxia. However, we discovered that beta-cell proliferation and beta-cell mass in Perk KO-betaTag islets substantially lagged behind wildtype-betaTag islets during the initial hyperplasia stage prior to the time that hypoxic conditions exist. Moreover, beta-cell death was actually slightly higher in the islets of the wildtype-betaTag mice during the exponential growth phase and therefore does not contribute to the relatively small size of the Perk KO-betaTag islets. Thus we suggest that PERK has two roles in tumor formation, first to support rapid cell proliferation and then later to promote angiogenesis. In the absence of PERK, however, tumors may not achieve sufficient size in order for severe hypoxia and cell death to occur. We found high apparent beta-cell death only in a very large wildtype-betaTag insulinoma, but similarly sized insulinomas were never seen in Perk KO-betaTag mice. To examine PERK's role in late stage tumor progression it will be necessary to acutely ablate PERK expression later in tumor development.
###end p 38
###begin p 39
###xml 232 236 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 447 451 447 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
In addition to regulating beta-cell functions that contribute tumor progression, PERK may also regulate functions in other cell types including the vascular endothelial cells that comprise the tumor macroenvironment. In our studies Perk is deficient in all cells of the entire animal, and therefore we cannot discriminate between PERK's functions in these different cell types. We are currently generating Tag-induced insulinomas in mice in which Perk has been specifically ablated in various cell types of the pancreas to determine the role of PERK in both the beta-cells and macroenvironment of the developing tumor.
###end p 39
###begin p 40
###xml 165 169 165 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 311 315 311 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 353 357 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Zhang2">[13]</xref>
The molecular mechanism underlying PERK-dependent regulation of tumor growth and angiogenesis is unknown. We speculate that reduced proliferation and vascularity in Perk-deficient insulinomas is caused by a fundamental defect in function in the secretory pathway that we have recently discovered in beta-cells. Perk-deficient beta-cells have defects in [13] ER to Golgi trafficking, ER associated proteasomal degradation, and integrity of the ER and Golgi (unpublished). Cell proliferation and membrane targeting of angiogenic receptors (e.g. VEGFRs) are highly dependent upon normal ER functions. We therefore suggest that these defects in ER functions may negatively impact beta-cell proliferation and angiogenesis.
###end p 40
###begin title 41
Ethics
###end title 41
###begin p 42
All the procedures that involved animal subjects were approved by the IACUC of the Pennsylvania State University in accordance with federal and state regulations governing care and use of animals.
###end p 42
###begin title 43
Materials and Methods
###end title 43
###begin title 44
Genetic Strains
###end title 44
###begin p 45
###xml 105 112 105 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet-Tag</italic>
###xml 147 156 147 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIP7-rtTA</italic>
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Berkovich1">[15]</xref>
###xml 242 249 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;Tag</italic>
###xml 567 571 564 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Perk</italic>
###xml 571 574 568 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 583 587 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008008-Zhang1">[12]</xref>
###xml 600 611 597 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKO-&#946;Tag</italic>
###xml 616 626 610 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT-&#946;Tag</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 16 20 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 113 128 <span type="species:ncbi:10090">transgenic mice</span>
###xml 157 172 <span type="species:ncbi:10090">transgenic mice</span>
###xml 214 229 <span type="species:ncbi:10090">transgenic mice</span>
###xml 432 447 <span type="species:ncbi:10090">transgenic mice</span>
###xml 471 475 <span type="species:ncbi:10090">mice</span>
###xml 536 540 <span type="species:ncbi:10090">mice</span>
###xml 627 631 <span type="species:ncbi:10090">mice</span>
Mice expressing SV40 large T-antigen conditionally in beta-cells were generated by crossing heterozygous tet-Tag transgenic mice with heterozygous RIP7-rtTA transgenic mice [15]. To activate Tag expression, double-transgenic mice (denoted as betaTag) were treated with 2 mg/ml doxycycline (Sigma) (in 2.5% sucrose) in their drinking water. Doxycycline treatment was administered in utero and continued postnatally. Untreated double-transgenic mice or doxycycline-treated mice lacking one of the two transgenes served as controls. These mice were further crossed into Perk+/- strains [12] to generate PKO-betaTag and WT-betaTag mice. All the strains were in a mixed genetic background. All the procedures that involved animal subjects were approved by the IACUC of the Pennsylvania State University.
###end p 45
###begin title 46
Blood Glucose Measurements
###end title 46
###begin p 47
Blood samples were obtained from the tail and were measured for glucose concentration using the Accu-Chek or OneTouch Ultra glucometers.
###end p 47
###begin title 48
Histological Analyses and Immunohistochemistry
###end title 48
###begin p 49
###xml 39 40 39 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
After the animals were sacrificed by CO2 asphyxiation, the pancreata were removed, fixed in 4% paraformaldehyde, dehydrated, paraffin-embedded and sectioned. Sections were processed for immunohistochemistry or stained with hematoxylin and eosin (H & E) by standard procedures. Briefly, cells were permeabilized in 0.2% Triton-X in phosphate-buffered saline (PBS) for 10 minutes. In the case of BrdU, antigen retrieval was performed by boiling in citric buffer for 10 mins. This was followed by serial incubations with the appropriate primary and secondary antibodies. The following antibodies were used: insulin (Linco Research), glucagon (Santa Cruz), proinsulin (Beta-Cell Biology Consortium), and BrdU (DAKO). Appropriate secondary antibodies conjugated with Alexa Fluor 488 or 555 dye (Molecular Probes) were used to visualize the labels. DAPI was used for nuclear staining. Fluorescence images were captured and analyzed with a Nikon Eclipse E1000 microscope and Image-Pro Plus Software (Phase 3 Imaging Systems).
###end p 49
###begin title 50
Beta-Cell Mass and Proliferation Analysis
###end title 50
###begin p 51
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were injected intraperitoneally with 100 microg BrdU/gram body weight. The pancreata were removed 6 hrs later, and processed. For the estimation of beta-cell mass, embryonic pancreata were processed and all of the islets in a total of 6 tissue sections (covering the entire pancreas) were analyzed.
###end p 51
###begin title 52
Statistical Analysis
###end title 52
###begin p 53
###xml 59 60 59 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Statistical analysis was performed using Student's t-test; P<0.05 was accepted as significant. Error bars represent the standard error of mean (SEM).
###end p 53
###begin p 54
###xml 214 219 <span type="species:ncbi:10090">mouse</span>
We thank Sarah Kossak for technical assistance. We also thank Shimon Efrat (Sackler School of Medicine, Tel Aviv University) and Doug Hanahan (University of California, San Francisco) for the RIP7-rtTA and tet-Tag mouse strains.
###end p 54
###begin title 55
References
###end title 55
###begin article-title 56
Upregulated expression of the genes encoding translation initiation factors eIF-4E and eIF-2alpha in transformed cells.
###end article-title 56
###begin article-title 57
Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase.
###end article-title 57
###begin article-title 58
Expression of a translationally regulated, dominant-negative CCAAT/enhancer-binding protein beta isoform and up-regulation of the eukaryotic translation initiation factor 2alpha are correlated with neoplastic transformation of mammary epithelial cells.
###end article-title 58
###begin article-title 59
Translational control: the cancer connection.
###end article-title 59
###begin article-title 60
The PERK/eIF2alpha/ATF4 module of the UPR in hypoxia resistance and tumor growth.
###end article-title 60
###begin article-title 61
ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth.
###end article-title 61
###begin article-title 62
Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress.
###end article-title 62
###begin article-title 63
Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase.
###end article-title 63
###begin article-title 64
###xml 80 88 <span type="species:ncbi:9606">patients</span>
EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome.
###end article-title 64
###begin article-title 65
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival.
###end article-title 65
###begin article-title 66
###xml 89 93 <span type="species:ncbi:10090">mice</span>
PERK eIF2 alpha kinase is required to regulate the viability of the exocrine pancreas in mice.
###end article-title 66
###begin article-title 67
The PERK eukaryotic initiation factor 2 alpha kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas.
###end article-title 67
###begin article-title 68
PERK EIF2AK3 control of pancreatic beta cell differentiation and proliferation is required for postnatal glucose homeostasis.
###end article-title 68
###begin article-title 69
PERK is essential for neonatal skeletal development to regulate osteoblast proliferation and differentiation.
###end article-title 69
###begin article-title 70
###xml 67 82 <span type="species:ncbi:10090">transgenic mice</span>
Inducible and reversible beta-cell autoimmunity and hyperplasia in transgenic mice expressing a conditional oncogene.
###end article-title 70
###begin article-title 71
###xml 28 32 <span type="species:ncbi:10090">mice</span>
Genetic rescue of Cdk4 null mice restores pancreatic beta-cell proliferation but not homeostatic cell number.
###end article-title 71
###begin article-title 72
Rapid vascular regrowth in tumors after reversal of VEGF inhibition.
###end article-title 72
###begin article-title 73
The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors.
###end article-title 73
###begin article-title 74
Oncogenic co-operation in beta-cell tumorigenesis.
###end article-title 74
###begin article-title 75
The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.
###end article-title 75
###begin article-title 76
Role of angiogenesis in tumor growth and metastasis.
###end article-title 76
###begin p 77
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 77
###begin p 78
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by grants from the National Institutes of Health (R01-DK062049 and R01-GM56957) and the Pennsylvania Department of Health TSF to D.R.C. and from the American Heart Association Fellowship to S.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 78

